ESR1 and Alzheimer disease: A particularly attractive feature of future studies is to explore the selective estrogen receptor modulators to normalize hyperactive glial cells and the release of proinflammatory cytokines and chemokines in inflammation, not only in AD, but also in other neurological disorders accompanied by excessive gliosis [80].